<DOC>
	<DOCNO>NCT01311635</DOCNO>
	<brief_summary>The purpose study study relative bioavailability AZD1981 use new tablet compare current tablet .</brief_summary>
	<brief_title>A Bioavailability Study Comparing 3 Different AZD1981 Tablets</brief_title>
	<detailed_description />
	<criteria>Healthy male postmenopausal surgically sterile female volunteer age 1855 , inclusive Have body mass index 1930 kg/m2 weigh least 50 kg 100 kg , inclusive Be nonsmoker exsmoker stop smoke &gt; 6 month prior screen Volunteers must willing use barrier method contraceptive , unless partner postmenopausal , surgically sterile use accepted contraceptive method . Any clinically significant disease disorder Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , urinalysis , vital sign ( include body temperature ) , ECG assessments Visit 1 , vital sign ( include body temperature ) Visit 2 Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m Visit 1 family history long QT syndrome History , current alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>bioavailability study</keyword>
	<keyword>AZD1981</keyword>
	<keyword>tablet</keyword>
	<keyword>To study relative bioavailability single dose AZD1981 via three different tablet</keyword>
	<keyword>To compare bioavailability three different AZD1981 tablet</keyword>
</DOC>